{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:27:24Z","timestamp":1760142444297,"version":"build-2065373602"},"reference-count":12,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Fran\u00e7aises d'Anesth\u00e9sie et de R\u00e9animation"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.annfar.2009.08.004","type":"journal-article","created":{"date-parts":[[2009,10,18]],"date-time":"2009-10-18T04:17:54Z","timestamp":1255839474000},"page":"885-888","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Imputabilit\u00e9 d\u2019une mise en jeu du pronostic vital \u00e0 un inhibiteur sp\u00e9cifique de la thrombine"],"prefix":"10.1016","volume":"28","author":[{"given":"W.","family":"Hanf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Duntze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Hida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Q.","family":"Blanc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Reynaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annfar.2009.08.004_bib1","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.2165\/00003495-200868120-00007","article-title":"Dabigatran etexilate","volume":"68","author":"Sanford","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.annfar.2009.08.004_bib2","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1517\/14656566.9.14.2509","article-title":"New therapeutic option for thromboembolism\u2013dabigatran etexilate","volume":"9","author":"Nishio","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.annfar.2009.08.004_bib3","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(07)61445-7","article-title":"Dabigatran etexilate versus enoxoparin for prevention of venous thromboembolism after total hip replacement: a randomised, double blind, non inferior trial","volume":"15","author":"Eriksson","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.annfar.2009.08.004_bib4","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1111\/j.1538-7836.2007.02748.x","article-title":"Oral dabigatran etexilate vs. subcutaneaous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomised trial","volume":"5","author":"Erikson","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.annfar.2009.08.004_bib5","doi-asserted-by":"crossref","unstructured":"Boyer-Neumann C, Wolf M, Parent F. Nouveaux antithrombotiques veineux. Encycl Med Chir (Elsevier, Paris). H\u00e9matologie 2006: 13-022-G-10.","DOI":"10.1016\/S1155-1984(06)41938-5"},{"key":"10.1016\/j.annfar.2009.08.004_bib6","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJMra044440","article-title":"Direct thrombin inhibitors","volume":"8","author":"Di Nisio","year":"2005","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.annfar.2009.08.004_bib7","first-page":"60","article-title":"Factor\u00a0Xa or thrombin: is thrombin a better target?","volume":"5","author":"Weitz","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.annfar.2009.08.004_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0003-4509(07)90021-8","article-title":"Nouveaux anticoagulants","volume":"65","author":"Samama","year":"2007","journal-title":"Ann Pharm Fr"},{"key":"10.1016\/j.annfar.2009.08.004_bib9","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/eurheartj\/ehm575","article-title":"New oral anticoagulants in atrial fibrillation","volume":"29","author":"Turpie","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.annfar.2009.08.004_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arth.2008.01.132","article-title":"Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery","volume":"24","author":"Ginsberg","year":"2009","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.annfar.2009.08.004_bib11","first-page":"2","article-title":"Efficacy and safety of dabigatran etexilate for the prevention of venous thromboembolism following total hip or knee arthroplasty. A meta-analysis","volume":"101","author":"Wolowacz","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.annfar.2009.08.004_bib12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/BRS.0b013e318195601d","article-title":"Thromboembolic disease in spinal surgery","volume":"34","author":"Glotzbecker","year":"2009","journal-title":"Spine"}],"container-title":["Annales Fran\u00e7aises d'Anesth\u00e9sie et de R\u00e9animation"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0750765809004730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0750765809004730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:10:29Z","timestamp":1760091029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0750765809004730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":12,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0750765809004730"],"URL":"https:\/\/doi.org\/10.1016\/j.annfar.2009.08.004","relation":{},"ISSN":["0750-7658"],"issn-type":[{"type":"print","value":"0750-7658"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imputabilit\u00e9 d\u2019une mise en jeu du pronostic vital \u00e0 un inhibiteur sp\u00e9cifique de la thrombine","name":"articletitle","label":"Article Title"},{"value":"Annales Fran\u00e7aises d'Anesth\u00e9sie et de R\u00e9animation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annfar.2009.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}